Skip to main content
LABT
NASDAQ Life Sciences

Lakewood-Amedex Reports Wider Q1 Losses, ($0.20) EPS and Negative Revenue

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.708
Mkt Cap
$9.906M
52W Low
$0.69
52W High
$9.82
52W Position info
2.7% above low
Off High info
93% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

LABT is trading near its 52-week low of $0.69 (2.7% above the low) on light trading volume (0.1× avg).

Summary

Lakewood-Amedex Biotherapeutics reported wider Q1 2026 losses, with revenue at ($886.75K), a net loss of ($923.29K), and diluted EPS of ($0.2). All key financial metrics worsened year-over-year. This earnings summary follows the company's recent 10-Q filing, which disclosed a persistent going concern warning and significant net losses. For a micro-cap company already trading near its 52-week low, these worsening financial results highlight continued cash burn and a precarious financial position, despite a recent $6.8 million Series C financing.

At the time of this announcement, LABT was trading at $0.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $0.69 to $9.82. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

LABT - Latest Insights

LABT
Nov 16, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.245
Real-time Price: $0.235 info
Change: -$0.010 (-4%) info
Market Cap: $2.192M info
LABT
Nov 16, 2026, 4:35 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.230
Real-time Price: $0.235 info
Change: +$0.0050 (+2%) info
Market Cap: $2.192M info
LABT
Nov 10, 2026, 5:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.402
Real-time Price: $0.235 info
Change: -$0.167 (-42%) info
Market Cap: $2.192M info
LABT
Sep 28, 2026, 5:49 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $0.235 info
Change: -$0.835 (-78%) info
Market Cap: $2.192M info
LABT
Sep 24, 2026, 8:02 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.80
Real-time Price: $0.235 info
Change: -$1.57 (-87%) info
Market Cap: $2.192M info